CD24 and breast carcinoma: Similar results were also demonstrated in BT-474 luminal B breast cancer cells (Supplementary Fig. 11c) from sphere-formation assay (Supplementary Fig. 11d, e) and flow cytometry analysis of CD24−/CD44+ expression (Supplementary Fig. 11f, g).